NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment

Trial Profile

NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Pioglitazone (Primary) ; Vitamin E
  • Indications Non-alcoholic steatohepatitis; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 01 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top